Patient & HCP Communication Strategies

4 Creative Pharma Communication Strategies to Drive Engagement and Trust

The pharmaceutical and life sciences industry is evolving rapidly, but one challenge persists: how to communicate complex science clearly and creatively. In an era of omnichannel communication where patient-centricity is the cornerstone of trust and engagement, pharma companies must go beyond traditional formats to deliver content that resonates with healthcare professionals (HCPs), patients, caregivers, and…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Artificial Intelligence and Writing

Breaking Barriers: Exploring the Power of AI and NLP in Scientific Communication

Learn how medical publication professionals and medical affairs teams can embrace AI and NLP tools...

A Guide to Creating a Robust Patient Engagement Strategy

Get started on effective patient engagement in your pharmaceutical or biotech company with our comprehensive...

Medical Information in the Digital Age – Quick and Efficient Meets Responsive and Responsible

Medical Information (MI teams across the pharmaceutical industry respond to product-related medical queries from HCPs...
Plain Language Clinical Trial Summaries

Why Do Plain Language Clinical Trial Summaries Matter?

Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...

Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences

The growth and adoption of the internet and mobile technology have provided publishers and authors...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.